Deep Brain Stimulation Technologies Pty Ltd is a rapidly developing company owned by the Bionics Institute of Australia, founders, and private investors. DBS Tech was founded in 2019 and has grown to a team of 16 researchers and development engineers. Its mission is to benefit patients living with neurological disorders via commercialisation of research outcomes into innovative treatment devices. DBS Technologies collaborates closely with a major international partner that will provide the translational pathway into clinical applications worldwide. The company’s science and development group is led by Professor Hugh McDermott and is based in East Melbourne. The practical activities are managed by the Chief Operating Officer, Dr Paul Minty.
